American Century Companies Inc. increased its position in shares of Aflac (NYSE:AFL) by 101.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,513,558 shares of the financial services provider’s stock after purchasing an additional 1,765,264 shares during the quarter. American Century Companies Inc. owned 0.45% of Aflac worth $153,753,000 as of its most recent filing with the SEC.
Other hedge funds have also recently modified their holdings of the company. Mutual of America Capital Management LLC increased its position in Aflac by 1.2% during the fourth quarter. Mutual of America Capital Management LLC now owns 48,300 shares of the financial services provider’s stock worth $4,240,000 after buying an additional 585 shares in the last quarter. Somerset Trust Co increased its position in Aflac by 2.6% during the fourth quarter. Somerset Trust Co now owns 24,941 shares of the financial services provider’s stock worth $2,190,000 after buying an additional 641 shares in the last quarter. Thrivent Financial For Lutherans increased its position in Aflac by 2.5% during the fourth quarter. Thrivent Financial For Lutherans now owns 26,923 shares of the financial services provider’s stock worth $2,364,000 after buying an additional 644 shares in the last quarter. GWM Advisors LLC increased its position in Aflac by 8.5% during the fourth quarter. GWM Advisors LLC now owns 8,469 shares of the financial services provider’s stock worth $762,000 after buying an additional 667 shares in the last quarter. Finally, Lingohr & Partner Asset Management GmbH increased its position in Aflac by 2.7% during the fourth quarter. Lingohr & Partner Asset Management GmbH now owns 26,652 shares of the financial services provider’s stock worth $2,339,000 after buying an additional 695 shares in the last quarter. 41.95% of the stock is owned by hedge funds and other institutional investors.
In other Aflac news, insider June P. Howard sold 2,648 shares of the business’s stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $90.33, for a total transaction of $239,193.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles B. Knapp sold 10,000 shares of the business’s stock in a transaction dated Monday, March 26th. The shares were sold at an average price of $43.72, for a total value of $437,200.00. Following the sale, the director now directly owns 76,582 shares of the company’s stock, valued at approximately $3,348,165.04. The disclosure for this sale can be found here. 3.00% of the stock is currently owned by insiders.
Shares of NYSE:AFL opened at $45.53 on Friday. The firm has a market capitalization of $35.15 billion, a PE ratio of 12.56, a price-to-earnings-growth ratio of 1.76 and a beta of 0.94. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.22. Aflac has a 52 week low of $44.95 and a 52 week high of $45.35.
Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, April 25th. The financial services provider reported $1.05 EPS for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.08. Aflac had a return on equity of 12.39% and a net margin of 20.61%. The business had revenue of $5.46 billion during the quarter, compared to the consensus estimate of $5.48 billion. During the same quarter in the previous year, the business earned $1.47 earnings per share. The business’s revenue for the quarter was up 2.9% on a year-over-year basis. research analysts anticipate that Aflac will post 3.95 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Wednesday, May 23rd will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date is Tuesday, May 22nd. Aflac’s dividend payout ratio (DPR) is presently 30.59%.
Several equities analysts have weighed in on the company. Zacks Investment Research downgraded Aflac from a “buy” rating to a “hold” rating in a research report on Monday. JPMorgan Chase set a $47.00 price target on Aflac and gave the stock a “buy” rating in a research report on Thursday, April 26th. Credit Suisse Group assumed coverage on Aflac in a research report on Wednesday, April 25th. They set a “neutral” rating and a $49.00 price target for the company. Wells Fargo set a $48.00 price target on Aflac and gave the stock a “hold” rating in a research report on Wednesday, April 25th. Finally, Morgan Stanley raised their price target on Aflac from $22.75 to $46.00 and gave the stock an “equal weight” rating in a research report on Tuesday, March 27th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, three have assigned a buy rating and two have issued a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $46.46.
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.